MDGL - Big 300% move after successful trials for company's liver disease drug - Been consolidating. Failed to breakout in Jan from tight range - Inside-day bar on Tue, coming after bullish reversal candle on Mon. Potential early entry
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.